Shorter answers, fluent chemistry, a verifier that grades itself: fluency is not verification
Terse reasoning is not better reasoning, fluent chemistry text can still be wrong, and a bounty verifier that grades its own claims is not a check at all.
Updated 2026-11-08 00:00 UTC
9 stories, 26 Manifests cited.
Artificial Intelligence
The investor test for AI has changed: robots must earn their keep, and moats must be real
Big cheques are still being written, but the questions behind them have hardened: what does the machine earn per hour, and what stops a rival copying it?
Agents are learning to cost less: shorter reasoning, traced spend, and retries that don't double-send
Open reasoning models are cutting filler, tracing now shows what each call costs, and a simple transactional pattern stops retries from sending the same alert twice.
Research & Science
Three preprints map biology's control knobs: chromatin, neurons, and a tumor's metabolism
In three preprints, researchers profile chromatin and gene activity together in the aging brain, steer simulated neurons with a fraction of the channels, and tie a pancreatic tumor's shape to its methionine cycle.
Finance & Investing
Lagarde steps down early to speak freely while central banks hold the line
Christine Lagarde is leaving the ECB a little less than nine months early. The Fed, meanwhile, is sitting still at 3.9%, after raising rates in September for the first time in three years.
Stocks fell. Credit didn't: households kept borrowing and bank deposits kept growing
Equities had a rough week, but the credit numbers kept pointing the other way: more borrowing, more deposits, and a small fall in the 10-year yield.
Business Podcasts
The podcasts' second verdict on the selloff: forget the election, this is a cash-flow test now
All-In, Fast Money and Bloomberg Surveillance converge on a new verdict: the AI selloff is now judged on cash flow, data-center supply and household budgets, not the election.
Health & Biotech
Clinical AI's week: a trial proves it works, a startup says aim it at regulation, Medicare sets the pay
The PARAMOUNT trial met its endpoint for AI-guided heart care, Weave Bio argued drug-development AI should target regulation, and CMS finalised 2027 Medicare payment rules.
Federal Government
NASA's Moon Base week: new contracts, a nuclear rover, and a call for astronauts
NASA announced Moon Base awards, opened astronaut applications, and named a nuclear-powered rover, PROMISE — with SpaceX's launch sites as the background capacity that flies the missions.